Roswell Park Cancer Institute Corporation — Buffalo, New York

Roswell Park Cancer Institute Corporation is a clinical research site located in Buffalo, New York, United States 14263.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Roswell Park Cancer Institute Corporation has participated in 1 clinical trials.

Therapeutic areas: Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia.

Sponsors: Astellas Pharma Inc.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Roswell Park Cancer Institute Corporation?

Roswell Park Cancer Institute Corporation has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Roswell Park Cancer Institute Corporation conducted?

Roswell Park Cancer Institute Corporation has 1 clinical trials on record. Their work covers Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia.

Is Roswell Park Cancer Institute Corporation accredited by Crixeo Health?

Roswell Park Cancer Institute Corporation has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Roswell Park Cancer Institute Corporation?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.